It is a quick procedure, and do not require any downtime
(8) C Spana, R Jordan, and S Fischkoff (2022) Effect of bremelanotide on body weight of obese women: Data from two phase 1 randomized controlled trials Diabetes Obesity & Metabolism, 2022 Mar 15, Volume 24 (Issue 6), Pages 10841093
GLP-1-based treatments are administered subcutaneously and work by supporting your bodys natural processes for appetite suppression and slowing gastric emptying, which may contribute to a feeling of fullness
Sources Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial (2024) Journal of the American Medical Association [Accessed 2 December 2025] Dosing Schedule | Ozempic (semaglutide) (2025) [Accessed 2 December 2025] GIP and GLP1, the two incretin hormones: Similarities and differences (2010) Journal of Diabetes Investigation [Accessed 2 December 2025] Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021) New England Journal of Medicine [Accessed 2 December 2025]
Bedrosian notes that while bariatric surgery remains the gold standard for weight loss, medications like Ozempic and Wegovy, as well as Mounjaro (FDA-approved to treat type 2 diabetes) and Zepbound (FDA-approved for weight loss) offer a valuable option for individuals who don't qualify for or aren't interested in surgery
